| Dr Jared Dean Olson, MD | |
|
12605 E 16th Ave, Aurora, CO 80045-2545 | |
| (720) 848-0000 | |
| Not Available |
| Full Name | Dr Jared Dean Olson |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine & Rehabilitation |
| Location | 12605 E 16th Ave, Aurora, Colorado |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053576033 | NPI | - | NPPES |
| 1053576033 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | MD60234837 (Washington) | Secondary |
| 208100000X | Physical Medicine & Rehabilitation | DR.0056803 (Colorado) | Primary |
| Entity Name | University Physicians Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962461889 PECOS PAC ID: 3476465667 Enrollment ID: O20031105000375 |
News Archive
Trius Therapeutics, Inc., a biopharmaceutical company developing innovative antibiotics for serious, life-threatening infections, announced today the initial public offering of 10,000,000 shares of its common stock at a price of $5.00 per share. The common stock is expected to begin trading on the NASDAQ Global Market on August 3, 2010 under the trading symbol "TSRX." Trius has granted the underwriters a 45 day option to purchase up to 750,000 shares of its common stock at the initial public offering price to cover over-allotments, if any.
With Minnesota's extreme heat, the Minnesota Chiropractic Association (MCA) would like to remind the public to take extra precautionary measures to ensure a safe and enjoyable summer.
AMAG Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has accepted for review the company's supplemental new drug application (sNDA) for Feraheme (ferumoxytol) Injection for Intravenous (IV) use, which was submitted to the FDA in December 2012.
A team of researchers at McGill University have discovered a molecular basis for the potential cancer preventive effects of vitamin D. The team, led by McGill professors John White and David Goltzman, of the Faculty of Medicine's Department of Physiology, discovered that the active form of vitamin D acts by several mechanisms to inhibit both the production and function of the protein cMYC.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jared Dean Olson, MD 5450 Western Ave, Boulder, CO 80301-2709 Ph: (303) 440-2250 | Dr Jared Dean Olson, MD 12605 E 16th Ave, Aurora, CO 80045-2545 Ph: (720) 848-0000 |
News Archive
Trius Therapeutics, Inc., a biopharmaceutical company developing innovative antibiotics for serious, life-threatening infections, announced today the initial public offering of 10,000,000 shares of its common stock at a price of $5.00 per share. The common stock is expected to begin trading on the NASDAQ Global Market on August 3, 2010 under the trading symbol "TSRX." Trius has granted the underwriters a 45 day option to purchase up to 750,000 shares of its common stock at the initial public offering price to cover over-allotments, if any.
With Minnesota's extreme heat, the Minnesota Chiropractic Association (MCA) would like to remind the public to take extra precautionary measures to ensure a safe and enjoyable summer.
AMAG Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has accepted for review the company's supplemental new drug application (sNDA) for Feraheme (ferumoxytol) Injection for Intravenous (IV) use, which was submitted to the FDA in December 2012.
A team of researchers at McGill University have discovered a molecular basis for the potential cancer preventive effects of vitamin D. The team, led by McGill professors John White and David Goltzman, of the Faculty of Medicine's Department of Physiology, discovered that the active form of vitamin D acts by several mechanisms to inhibit both the production and function of the protein cMYC.
› Verified 3 days ago
David Reinhard, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1390 S Potomac St, Ste 100, Aurora, CO 80012 Phone: 303-341-0722 Fax: 303-341-0832 | |
Heather Baer, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Anne Stratton, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Gretchen Brunworth, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 830 Potomac Cir, Suite 209, Aurora, CO 80011 Phone: 303-341-4785 Fax: 303-341-1479 | |
Raymond C Jones, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 12631 E 17th Ave., Ao1, Rm.2513, Dept. Of Pm&r, Aurora, CO 80045 Phone: 303-724-1263 | |
Barry A Ogin, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1390 S Potomac St, Ste 100, Aurora, CO 80012 Phone: 303-341-0722 Fax: 303-341-0832 |